Editorials Safety, trust, and money are uncomfortable bedfellows BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5750 (Published 03 November 2015) Cite this as: BMJ 2015;351:h5750 Article Related content Metrics Responses Peer review Related articles Research Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink Published: 03 November 2015; BMJ 351 doi:10.1136/bmj.h5501 Paper Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Published: 01 July 2004; BMJ 329 doi:10.1136/bmj.329.7456.15 ResearchExamining variations in prescribing safety in UK general practice See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
